Steady-state and inflammatory dendritic-cell development

被引:891
作者
Shortman, Ken [1 ]
Naik, Shalin H. [1 ]
机构
[1] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia
基金
英国医学研究理事会;
关键词
D O I
10.1038/nri1996
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The developmental pathways that lead to the production of antigen-presenting dendritic cells (DCs) are beginning to be understood. These are the last of the pathways of haematopoiesis to be mapped. The existence of many specialized subtypes of DC has complicated this endeavour, as has the need to distinguish the DCs formed in steady state from those produced during an inflammatory response. Here we review studies that lead to the concept that different types of DC develop through different branches of haematopoietic pathways that involve different immediate precursor cells. Furthermore, these studies show that many individual tissues generate their own DCs locally, from a reservoir of immediate DC precursors, rather than depending on a continuous flux of DCs from the bone marrow.
引用
收藏
页码:19 / 30
页数:12
相关论文
共 130 条
[11]   Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance [J].
Bonifaz, L ;
Bonnyay, D ;
Mahnke, K ;
Rivera, M ;
Nussenzweig, MC ;
Steinman, RM .
JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 196 (12) :1627-1638
[12]   A role for endogenous transforming growth factor beta 1 in Langerhans cell biology: The skin of transforming growth factor beta 1 null mice is devoid of epidermal Langerhans cells [J].
Borkowski, TA ;
Letterio, JJ ;
Farr, AG ;
Udey, MC .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (06) :2417-2422
[13]   Generation of murine dendritic cells from flt3-ligand-supplemented bone marrow cultures [J].
Brasel, K ;
De Smedt, T ;
Smith, JL ;
Maliszewski, CR .
BLOOD, 2000, 96 (09) :3029-3039
[14]   Murine plasmacytoid pre-dendritic cells generated from Flt3 ligand-supplemented bone marrow cultures are immature APCs [J].
Brawand, P ;
Fitzpatrick, DR ;
Greenfield, BW ;
Brasel, K ;
Maliszewski, CR ;
De Smedt, T .
JOURNAL OF IMMUNOLOGY, 2002, 169 (12) :6711-6719
[15]  
Bruno L, 2001, EUR J IMMUNOL, V31, P3403, DOI 10.1002/1521-4141(200111)31:11<3403::AID-IMMU3403>3.0.CO
[16]  
2-T
[17]   Homing phenotypes of tumor-specific CD8 T cells are predetermined at the tumor site by crosspresenting APCs [J].
Calzascia, T ;
Masson, F ;
Di Berardino-Besson, W ;
Contassot, E ;
Wilmotte, R ;
Aurrand-Lions, M ;
Rüegg, C ;
Dietrich, PY ;
Walker, PR .
IMMUNITY, 2005, 22 (02) :175-184
[18]   TUMOR-NECROSIS-FACTOR-ALPHA COOPERATES WITH INTERLEUKIN-3 IN THE RECRUITMENT OF A PRIMITIVE SUBSET OF HUMAN CD34+ PROGENITORS [J].
CAUX, C ;
DURAND, I ;
MOREAU, I ;
DUVERT, V ;
SAELAND, S ;
BANCHEREAU, J .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 177 (06) :1815-1820
[19]   CD34(+) hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+TNF alpha [J].
Caux, C ;
Vanbervliet, B ;
Massacrier, C ;
DezutterDambuyant, C ;
deSaintVis, B ;
Jacquet, C ;
Yoneda, K ;
Imamura, S ;
Schmitt, D ;
Banchereau, J .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (02) :695-706
[20]   Interleukin-3 cooperates with tumor necrosis factor alpha for the development of human dendritic Langerhans cells from cord blood CD34(+) hematopoietic progenitor cells [J].
Caux, C ;
Vanbervliet, B ;
Massacrier, C ;
Durand, I ;
Banchereau, J .
BLOOD, 1996, 87 (06) :2376-2385